30 Dec 2024 Compass Lexecon Client Prudential Prevails in ERISA Class Action Financial Institutions & Products
17 Dec 2024 Belgian Court of Appeal dismisses European Commission’s multi-million damages claim from elevators cartel Manufacturing
16 Dec 2024 Compass Lexecon Veterinary Clients Obtain FTC Merger Clearance Healthcare & Life Sciences
Insights abuse of dominance Search Search insight Filters Services… Antitrust & Competition Antitrust & Competition: Mergers Antitrust & Competition: Conduct Mergers & Acquisition Litigation Industries… Healthcare & Life Sciences abuse of dominance Clear all Showing 1–2 of 2 results Article • 31 Oct 2024 Guidelines without Guidance: Roundtable discussion on the draft Article 102 guidelines Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry
Article • 31 Oct 2024 Guidelines without Guidance: Roundtable discussion on the draft Article 102 guidelines
Article • 27 Aug 2024 GCR The Guide to Life Sciences: An Economist’s Perspective on Abuse of Dominance and Killer Acquisitions in the Pharma Industry